Lupin stock rises after pharma major gets US FDA approval for its ... - dofaq.co
Lupin stock rises after pharma major gets US FDA approval for its ...
Lupin shares decline 0.22% as Sensex climbs
Lupin rises after US FDA gives pharma firm EIR for its Aurangabad facility
USFDA issues inspection report for Lupin's Aurangabad manufacturing facility
USFDA issues EIR for Lupin Aurangabad facility
Lupin launches generic drug in US market
Drug maker Lupin launches Mirabegron extended-release tablets in US market
Lupin unveils Mirabegron ER tablets in US
Stocks in Focus: Lupin, Hindustan Zinc, MCX, and Others
Lupin receives EIR from USFDA for its Aurangabad manufacturing facility
Buy Lupin, target price Rs 1770: Axis Securities
Lupin's Aurangabad facility gets zero adverse observations in US FDA's latest inspection
Lupin shares down 1.2% as Sensex rises
Traders Diary: Buy, sell or hold strategy on RVNL, IGL, Lupin, Exide, Cummins, over a dozen other stocks to...
Aditya Arora on 2 top trading picks in a volatile market
Lupin gets USFDA nod to launch generic tablet to treat overactive bladder
Lupin receives establishment inspection report from USFDA, inspection conducted from March 6 to March 15
Lupin receives EIR from US FDA for its Aurangabad manufacturing facility
Lupin rises over 3% after US FDA approves Mirabegron tablets
Stocks to Watch: Tata Consumer, HUL, ICICI Pru., Tata Elxsi, Lupin, Dr Reddy's | Mint
